#United States #Indianapolis #Elanco #TruCan #Canine Vaccine

Elanco's Groundbreaking Vaccine for Canine Health

In recent developments in veterinary medicine, Elanco Animal Health has announced significant advancements in pet care. The U.S. Department of Agriculture (USDA) has granted approval for TruCan™ Ultra Lyme-L4, the first-ever combination vaccine designed to protect dogs against both Lyme disease and leptospirosis with a minimal dosage of just 1/2 mL. This innovative vaccine is now an important addition to the TruCan Ultra portfolio, reflecting Elanco's commitment to enhancing pet wellness.

The Innovation Behind TruCan Ultra Lyme-L4

Historically, protecting dogs from Lyme disease and leptospirosis has required multiple injections, which can be uncomfortable and stressful for pets and their owners alike. The TruCan Ultra Lyme-L4 vaccine simplifies this process, condensing two essential vaccinations into one single, low-volume shot. By utilizing Elanco's proprietary PureFil™ Technology, this vaccine significantly minimizes the risk of adverse reactions typically associated with additional proteins present in traditional vaccines.

Elanco emphasizes that the minimizing of injections is a boon for veterinarians and pet owners. The less invasive approach encourages a more pleasant experience during wellness visits, mitigating stress for animals and their caregivers. According to Bobby Modi, Executive Vice President of U.S. Pet Health and Global Digital Transformation, this vaccine equips veterinarians with a powerful tool to address critical gaps in canine health protection, while also promoting a positive veterinary experience.

Why This Vaccine Matters

The approval of TruCan Ultra Lyme-L4 comes at a crucial time. All dogs are at risk for leptospirosis, regardless of their breed, size, or lifestyle. Moreover, Lyme disease is increasingly present in various geographical areas, with current statistics indicating that over 40% of at-risk dogs in endemic regions have not received their Lyme vaccinations. This poses a significant concern for existing pet health practices and highlights the necessity for proactive vaccinations.

Dr. Jessica Pritchard, a Clinical Assistant Professor in Small Animal Internal Medicine at the University of Wisconsin-Madison, stresses the importance of this vaccine: "Leptospirosis vaccination is now considered core for dogs, as exposure risks exist nationwide, including in suburban and urban areas. Proper vaccination, complemented by informed discussions on lifestyle risks between veterinarians and pet owners, is vital in safeguarding dogs from these preventable diseases."

Studies further bolster the vaccine's credibility, showing a powerful efficacy rate of 92.2% against natural infections in high-risk areas and a full 100% efficacy in controlled laboratory settings. The focus on reducing the number of injections required—one instead of two—aims to improve the overall experience during pet wellness visits for all involved, including veterinary staff.

Looking Ahead

TruCan Ultra Lyme-L4 is part of a broader strategy by Elanco, which has recently received USDA approval for other groundbreaking products within the TruCan Ultra line—including the first 1/2 mL oral Bordetella vaccine and the unique 1/2 mL bivalent canine influenza vaccine. The emphasis on low-volume and high-quality vaccines underscores Elanco's commitment to enhancing vaccination protocols tailored to the very specific needs of every dog.

Set to begin shipping within the next 30 days, the TruCan Ultra Lyme-L4 vaccine symbolizes a transformative step in veterinary medicine, allowing pet health professionals to deliver superior care efficiently. For further information on this innovative vaccine and to discover how it can help keep your dog healthy, visit Elanco's TruCan webpage.

About Elanco

Established as a leader in the animal health industry, Elanco Animal Health (NYSE: ELAN) is dedicated to innovating solutions that prevent and treat diseases in pets and farm animals. With over 70 years in the field, Elanco continues to push boundaries in animal health, striving to enrich the lives of animals, pet owners, and communities worldwide.